HeraMED Limited announced that it has entered into a partnership with Australian creative agency, Meerkats to progress the business to consumer (B2C) launch of HeraMED's medical grade foetal heart rate monitor, HeraBEAT in Australia. Meerkats is a leading Australian creative agency that has been assisting organizations to grow through creativity and innovation for 15 years. Boasting a national footprint, Meerkats services a range of top tier companies including St John Ambulance and iiNet amongst others. As part of the agreement, Meerkats will provide strategic consulting services in relation to HeraMED's branding, digital marketing, media strategy and social media initiatives in Australia. Both parties will collaborate to develop an extensive digital marketing campaign, expected to launch in May 2019. The partnership follows an extensive due diligence process undertaken by Meerkats into the HeraBEAT device and the Australian market. Following this process, Meerkats have chosen to undertake the project through its `Meerkats Ventures' approach, which sees the agency being remunerated via a small percentage of each device sold. Meerkats will receive a pre-negotiated commission from HeraMED's exclusive Australian distributor Dale Group International for each device sold in Australia. HeraMED believes that this development provides considerable validation of the HeraBEAT device and that this remuneration structure will incentivise Meerkats to drive product uptake throughout the region. The company advises that it has also received its first purchase order from the Dale Group International, comprising of 250 devices units.